MGTX
NASDAQ · Biotechnology
Meiragtx Holdings Plc
$9.84
+0.16 (+1.65%)
Open$9.71
Previous Close$9.68
Day High$9.85
Day Low$9.64
52W High$11.85
52W Low$4.55
Volume—
Avg Volume577.1K
Market Cap908.91M
P/E Ratio—
EPS$-1.43
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+540.3% upside
Current
$9.84
$9.84
Target
$63.01
$63.01
$47.40
$63.01 avg
$83.78
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 93.47M | 54.26M | 298.22M |
| Net Income | -131,154,907 | -68,520,007 | -30,982,952 |
| Profit Margin | -140.3% | -133.3% | -10.4% |
| EBITDA | -121,530,045 | -67,018,948 | -39,492,333 |
| Free Cash Flow | — | — | -35,501,473 |
| Rev Growth | +72.3% | +72.3% | -0.7% |
| Debt/Equity | 1.08 | 1.08 | 0.77 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |